Showing 1 - 10 of 165
Oped, Postbag, Published on 12/02/2026
» Re: "BJT win bodes well for conservatives", (BP, Feb 11). Given the tallies of the nationwide party list vote, I don't understand the justification for the following assertions: "BJT's landslide victory reflects a surge of nationalist sentiment" (5.9M votes); the PP suffered from "lingering voter scepticism" and "eroded public confidence" (9.8M votes).
Oped, Walter O Ochieng & Tom Achoki, Published on 06/02/2026
» For the past half-century, the economics of global health were straightforward. Under the so-called "grant-based" approach, rich countries donate to poor countries, which use the funds to meet their populations' health needs. Success was measured by services provided or lives saved, rather than by balance sheets. While this model was far from perfect, the latest approach replacing it -- focused on using tools like guarantees and blended finance to crowd in private capital -- threatens to produce even worse outcomes.
Oped, Gwynne Dyer, Published on 05/01/2026
» The demonstrations began again in Iran last week, only two years after the "Woman, Life, Freedom" movement convulsed the country for months. However, the current protests are potentially much broader than that episode because they are driven by the collapse in Iran's currency, the rial (now 1,420,000 to the US dollar), and the explosive rise in the cost of living.
Oped, Akihisa Nagashima, Published on 26/12/2025
» We are living in an age of global disruption. Supply chains are being reconfigured to avoid dependence on any one producer or country. Trade ties are being upended by high and unpredictable tariffs (and the threat of more). Longstanding alliances are being strained by doubts about partners' reliability.
Oped, Michael Burleigh, Published on 15/12/2025
» Until a few days ago, it had never crossed my mind that people across Europe -- including Londoners like me -- were living in a strife‑afflicted hell hole, "suffocated" by regulations, stripped of political liberties, and bound for "civilisational erasure". So, it was with some surprise that I read this assessment in the new US National Security Strategy -- a document that echoes pseudo‑intellectual propaganda more than resembling any serious foreign‑policy analysis.
Oped, Lee Jong-wha, Published on 27/11/2025
» Two decades after globalisation fuelled a global economic boom, growth has shifted onto a more subdued path, where it is likely to remain for the foreseeable future. Beyond the immediate shock of fragmenting trade and investment ties -- a result of rising geopolitical tensions, particularly between the United States and China -- lie structural headwinds, including population ageing, stagnant productivity, and the growing costs of inequality and natural disaster. These challenges strike at the heart of Asia's growth model.
Oped, Antara Haldar, Published on 12/11/2025
» With the 250th anniversary of The Wealth of Nations approaching next year, the world is gearing up to honour Adam Smith. But which Smith should be recognised? The hard-nosed "founding father" of modern economics, or the philosopher who wrote The Theory of Moral Sentiments? Scholars have wrestled with this question, a riddle known as "Das Adam Smith Problem", for centuries, because it concerns not just dualities within Smith's thought, but also our own uneasy relationship with morality and markets.
Oped, Watcharin Ariyaprakai, Published on 29/10/2025
» Thailand has made history by recognising same-sex marriage, affirming the right of adults to love and marry freely. This will rightly be celebrated as a triumph for equality and human dignity. Yet, in the same society, another group remains voiceless: newborns born with Disorders of Sex Development (DSD).
Oped, Peter Singer & Sankalpa Ghose, Published on 17/10/2025
» Even in an era of intense political polarisation, there are still moments when a bipartisan consensus can emerge around important ethical issues. One such moment is happening now. Last April, the United States Food and Drug Administration released its "Roadmap to Reducing Animal Testing in Preclinical Safety Studies". The FDA said that it was taking "a groundbreaking step" that would advance public health and limit wasteful expenditure by replacing animal testing with "more effective, human-relevant methods".
Oped, Editorial, Published on 09/10/2025
» The House of Representatives made good progress in pushing for the long-awaited amnesty bill this month. The bill, which is now known as the "peace-building legislation", was submitted early this month to the Lower House.